Tag: COVID19

Transitioning from incarceration to the community: Reducing risks and improving lives of people who use substances

To help incarcerated people who use substances successfully integrate back into their communities, Direction 180 started the Peers Assisting and Lending Support (PALS) program in January 2019 through harm reduction funding from the Public Health Agency of Canada.  Direction 180 is a community-based organization that offers an opioid treatment program in Halifax, Nova Scotia.

Read more

Satellite Sites: Providing harm reduction from the homes of people who use drugs

The term “satellite sites” is used to refer to informal harm reduction hubs operating out of the homes of people who use drugs. Operating in Toronto for more than 20 years, these sites offer access to sterile drug use supplies outside of more formal settings like health centres. Although many satellite sites offer much more than this – including naloxone and overdose response training, needle disposal and referrals to healthcare services. Satellite programs emerged from the recognition that people who use drugs were already doing this work within their communities, operating informally to meet harm reduction needs and respond to a range of other health needs.

Read more

COVID-19 in prisons: What needs to be done in Ontario

Immediately after Ontario declared the novel coronavirus disease (COVID-19) as being a public health emergency in mid-March 2020, all visits from family and friends and programming were suspended in prisons in the province.

With little information from the Ministry of the Solicitor General regarding their efforts to contain the spread of COVID-19, the Prisoners’ HIV/AIDS Support Action Network (PASAN) was flooded with phone calls from prisoners concerned about their health and the well-being of their family and friends.

Read more

Five ways to sustain the hepatitis C elimination efforts in Canada

This June, CATIE and the Canadian Network on Hepatitis C (CanHepC) co-hosted a webinar on sustaining the hepatitis C response before and after the novel coronavirus disease (COVID-19) pandemic. We invited leaders in the hepatitis C field to explore the challenges that the pandemic has posed for hepatitis C elimination efforts, but also the opportunities that could be leveraged. Here are just five of the ways we can do this:

Read more